Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report)’s share price gapped down prior to trading on Monday . The stock had previously closed at $284.97, but opened at $271.69. Astera Labs shares last traded at $268.4320, with a volume of 772,603 shares changing hands.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the stock. Citigroup reiterated a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Weiss Ratings reiterated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Jefferies Financial Group boosted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Barclays upped their target price on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Finally, JPMorgan Chase & Co. raised their target price on Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $333.00.
Read Our Latest Analysis on ALAB
Astera Labs Trading Down 2.7%
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue was up 104.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.
Insider Buying and Selling at Astera Labs
In related news, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director directly owned 1,287,524 shares of the company’s stock, valued at $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 419,244 shares of company stock worth $163,135,169. Insiders own 10.40% of the company’s stock.
Hedge Funds Weigh In On Astera Labs
Several institutional investors have recently made changes to their positions in ALAB. California State Teachers Retirement System lifted its stake in shares of Astera Labs by 49,273.2% in the 2nd quarter. California State Teachers Retirement System now owns 100,158,544 shares of the company’s stock valued at $48,378,580,000 after purchasing an additional 99,955,684 shares during the period. BlackRock Inc. acquired a new stake in Astera Labs during the second quarter valued at $6,609,581,000. Bank of America Corp DE acquired a new stake in Astera Labs during the second quarter valued at $1,061,791,000. Atreides Management LP increased its holdings in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Finally, Amundi increased its holdings in Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after buying an additional 1,319,643 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Read More
- Five stocks we like better than Astera Labs
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
- If Boeing Ramps Up Production, These Suppliers May Win Big
- Marvell Takes a Shot a Broadcom’s Throne With Google Deal
- 5 of the Most-Upgraded Stocks Over the Last Quarter Are All Software Names—Here’s Why
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
